Cardiac remodeling and angiotensin II-forming enzyme activity of the left ventricle in hamsters with chronic pressure overload induced by ascending aortic stenosis

Journal of Veterinary Medical Science

Volumn 68, Issue 3, 2006, Pages 271-276

  Shimizu, Miki ^a   Tanaka, Ryou ^a   Fukuyama, Tomoki ^a   Aoki, Ryoko ^b   Orito, Kensuke ^b   Yamane, Yoshihisa ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^b AZABU UNIVERSITY   (Japan)

Author keywords

Angiotensin converting enzyme; Chymase; Hamster; Remodeling; Renin angiotensin system

Indexed keywords

ANGIOTENSIN II; CHYMASE; DIPEPTIDYL CARBOXYPEPTIDASE; SERINE PROTEINASE;

ANIMAL; ANIMAL DISEASE; AORTA VALVE STENOSIS; ARTICLE; BIOSYNTHESIS; BODY WEIGHT; CONGESTIVE HEART FAILURE; CYTOCHEMISTRY; DISEASE MODEL; DOG; DOG DISEASE; ECHOCARDIOGRAPHY; ENZYMOLOGY; HAMSTER; HEART MUSCLE; HEART VENTRICLE; HEART VENTRICLE REMODELING; MALE; METABOLISM; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY; SYRIAN HAMSTER;

ANGIOTENSIN II; ANIMALS; AORTIC VALVE STENOSIS; BODY WEIGHT; CHYMASES; CRICETINAE; DISEASE MODELS, ANIMAL; DOG DISEASES; DOGS; ECHOCARDIOGRAPHY; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HISTOCYTOCHEMISTRY; MALE; MESOCRICETUS; MYOCARDIUM; ORGAN SIZE; PEPTIDYL-DIPEPTIDASE A; SERINE ENDOPEPTIDASES; VENTRICULAR REMODELING;

CANIS FAMILIARIS; CRICETINAE; MESOCRICETUS AURATUS; RODENTIA;

EID: 33645666936     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.68.271     Document Type: Article

References (35)

1. Balcells, E., Meng, Q. C., Johnson, W. H., Jr., Oparil, S. and Dell'Italia, L. J. 1997. Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations. Am. J. Physiol. 273: H1769-1774.
2. Barlucchi, L., Leri, A., Dostal, D. E., Fioidaliso, F., Tada, H., Hintze, T. H., Kajstura, J., Nadal-Ginard, B. and Anversa, P. 2001. Canine ventricular myocytes possess a renin-angiotensin system that is upregulated with heart failure. Circ. Res. 88: 298-304.
3. Busatto, V. C., Cicilini, M. A. and Mill, J. G. 1997. Increased angiotensin-converting enzyme activity in the left ventricle after infarction. Braz. J. Med. Biol. Res. 30: 679-687.
4. Campbell, S. E. and Katwa, L. C. 1997. Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. J. Mol. Cell. Cardiol. 29: 1947-1958.
5. Chancey, A. L., Brower, G. L., Peterson, J. T. and Janicki, J. S. 2002. Effects of matrix metalloproteinase inhibition on ventricular remodeling due to volume overload. Circulation 105: 1983-1988.
6. Cohn, J. N., Ferrari, R. and Sharpe, N. 2000. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J. Am. Coll. Cardiol. 35;569-582.
7. Dell'Italia, L. J., Meng, Q. C., Balcells, E., Straeter-Knowlen, I. M., Hankes, G. H., Dillon, R., Cartee, R. E., Orr, R., Bishop, S. P., Oparil, S. et al. 1995. Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation. Am. J. Physiol. 269: H2065-2073.
8. Dostal, D. E., Booz, G. W. and Baker, K. M. 2000. Regulation of angiotensinogen gene expression and protein in neonatal rat cardiac fibroblasts by glucocorticoid and beta-adrenergic stimulation. Basic Res. Cardiol. 95: 485-490.
9. Fujii, M., Wada, A., Ohnishi, M., Tsutamoto, T., Matsumoto, T., Yamamoto, T., Takayama, T., Dohke, T., Isono, T., Eguchi, Y. and Horie, M. 2004. Endogenous bradykinin suppresses myocardial fibrosis through the cardiac-generated endothelin system under chronic angiotensin-converting enzyme inhibition in heart failure. J. Cardiovasc. Pharmacol. 44: S346-S349.
10. Garg, R. and Yusuf, S. 1995. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. Jama. 273: 1450-1456.
11. Hollenberg, N. K. 2000. Implications of species difference for clinical investigation: studies on the renin-angiotensin system. Hypertension 35:150-154.
12. Ju, H. and Dixon, I. M. 1996. Effect of angiotensin II on myocardial collagen gene expression. Mol. Cell. Biochem. 163-164: 231-237.
13. Konstam, M. A., Rousseau, M. F., Kronenberg, M. W., Udelson, J. E., Melin, J., Stewart, D., Dolan, N., Edens, T. R., Ahn, S., Kinan, D. et al. 1992. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. Circulation 86:431-438.
14. Li, P., Chen, P. M., Wang, S. W. and Chen, L. Y. 2002. Time-dependent expression of chymase and angiotensin converting enzyme in the hamster heart under pressure overload. Hypertens. Res. 25: 757-762.
15. Litwin, S. E., Katz, S. E., Weinberg, E. O., Lorell, B. H., Aurigemma, G. P. and Douglas, P. S. 1995. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. Circulation 91: 2642-2654.
16. Mitsuhashi, S., Saito, N., Watano, K., Igarashi, K., Tagami, S., Shima, H. and Kikuchi, K. 2003. Defect of delta-sarcoglycan gene is responsible for development of dilated cardiomyopathy of a novel hamster strain, J2N-k: calcineurin/PP2B activity in the heart of J2N-k hamster. J. Biochem. 134: 269-276.
17. Nishimura, H., Buikema, H., Baltatu, O., Ganten, D. and Urata, H. 1998. Functional evidence for alternative ANG II-forming pathways in hamster cardiovascular system. Am. J. Physiol. 275:H1307-1312.
18. Orito, K., Yamane, T., Kanai, T., Fujii, Y., Wakao, Y. and Matsuda, H. 2004. Time course sequences of angiotensin converting enzyme and chymase-like activities during development of right ventricular hypertrophy induced by pulmonary artery constriction in dogs. Life Sci. 75: 1135-1145.
19. Sadoshima, J., Xu Y., Slayter, H. S. and Izumo, S. 1993. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75: 977-984.
20. Sanker, S., Chandrasekharan, U. M., Wilk, D., Glynias, M. J., Karnik, S. S. and Husain, A. 1997. Distinct multisite synergistic interactions determine substrate specificities of human chymase and rat chymase-1 for angiotensin II formation and degradation. J. Biol. Chem. 272 2963-2968.
21. Schulte, D., Su, X., Wei, C. C., Bishop, S. P., Powell, P., Hankes, G. H., Dillon, A. R., Rynders, P., Spinale, F. G., Walcott, G., Ideker, R. and Dell'Italia, L. J. 2002. Downregulation of ANG II receptor is associated with compensated pressure-overload hypertrophy in the young dog. Am. J. Physiol. Heart Circ. Physiol. 282: H749-756.
22. Schunkert, H., Dzau, V. J., Tang, S. S., Hirsch, A. T., Apstein, C. S. and Lorell, B. H. 1990. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation. J. Clin. Invest. 86: 1913-1920.
23. Sharma, H. S., van Heugten, H. A., Goedbloed, M. A., Verdouw, P. D. and Lamers, J. M. 1994. Angiotensin II induced expression of transcription factors precedes increase in transforming growth factor-beta 1 mRNA in neonatal cardiac fibroblasts. Biochem. Biophys. Res. Commun. 205:105-112.
24. Shiota, N., Jin, D., Takai, S., Kawamura, T., Koyama, M., Nakamura, N. and Miyazaki, M. 1997. Chymase is activated in the hamster heart following ventricular fibrosis during the chronic stage of hypertension. FEBS. Lett. 406: 301-304.
25. Stewart, J. A., Jr., Wei, C. C., Brower, G. L., Rynders, P. E., Hankes, G. H., Dillon, A. R., Lucchesi, P. A., Janicki, J. S. and Dell'Italia, L. J. 2003. Cardiac mast cell- and chymase-mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in the dog. J. Mol. Cell. Cardiol. 35:311-319.
26. Sun, Y., Ratajska, A. and Weber, K. T. 1995. Bradykinin receptor and tissue ACE binding in myocardial fibrosis: response to chronic angiotensin II or aldosterone administration in rats. J. Mol Cell. Cardiol. 27: 813-822.
27. Swedberg, K., Pfeffer, M., Granger, C., Held, P., McMurray, J., Ohlin, G., Olofsson, B., Ostergren, J. and Yusuf, S. 1999. Candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators. J. Card. Fail. 5:276-282.
28. Taipale, J., Lohi, J., Saarinen, J., Kovanen, P. T. and KeskiOja, J. 1995. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extra-cellular matrix of cultured human epithelial and endothelial cells. J. Biol. Chem. 270:4689-4696.
29. Takai, S., Jin, D., Sakaguchi, M., Katayama, S., Muramatsu, M., Matsumura, E., Kim, S. and Miyazaki, M. 2003. A novel chymase inhibitor, 4-[1-([bis-(4-methyl-phenyl)-methyl]-carbamoyl)3-(2-ethoxy-benzyl)-4-oxo-a zetidine-2-yloxy]-benzoic acid (BCEAB), suppressed cardiac fibrosis in cardiomyopathic hamsters. J. Pharmacol. Exp. Ther. 305: 17-23.
30. Tanaka, Y., Nagai, M., Date, T., Okada, T., Abe, Y., Seki, S., Taniguchi, M., Taniguchi, I. and Mochizuki, S. 2004. Effects of bradykinin on cardiovascular remodeling in renovascular hypertensive rats. Hypertens. Res. 27: 865-875.
31. Urata, H., Kinoshita, A., Misono, K. S., Bumpus, F. M. and Husain, A. 1990. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J. Biol. Chem. 265:22348-22357.
32. Weber, K. T. 2000. Targeting pathological remodeling: concepts of cardioprotection and reparation. Circulation 102: 1342-1345.
33. Wei, C. C., Meng, Q. C., Palmer, R., Hageman, G. R., Durand, J., Bradley, W. E., Farrell, D. M., Hankes, G. H., Oparil, S. and Dell'Italia, L. J. 1999. Evidence for angiotensin-converting enzyme- and chymase-mediated angiotensin II formation in the interstitial fluid space of the dog heart in vivo. Circulation 99: 2583-2589.
34. Weinberg, E. O., Lee, M. A., Weigner, M., Lindpaintner, K., Bishop, S. P., Benedict, C. R., Ho, K. K., Douglas, P. S., Chafizadeh, E. and Lorell, B. H. 1997. Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis. Circulation 95: 1592-1600.
35. Zhang, X., Dostal, D. E., Reiss, K., Cheng, W., Kajstura, J., Li, P., Huang, H., Sonnenblick, E. H., Meggs, L. G., Baker, K. M. and et al. 1995. Identification and activation of autocrine reninangiotensin system in adult ventricular myocytes. Am. J. Physiol. 269:H1791-1802.